Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2025 08:55 ET | Source: PharmAla Biotech

PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists

PharmAla launches new web portal for MDMA prescribers and appoints a new COO
September 08, 2025 10:11 ET | Source: Psychedelics Canada

PsyCan Discovers Sharp Decline in Health Canada Approvals for Doctors Seeking Legal Psychedelic Therapy for Patients

Psycan discloses troubling statistics showing that Health Canada has begun to deny numerous doctor requests for MDMA and Psilocybin
May 30, 2025 09:14 ET | Source: PharmAla Biotech

PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla

PharmAla warns the public that it does not sell MDMA to consumers, and to be on guard for illegitimate and fake products falsely being sold online.
April 01, 2025 09:00 ET | Source: Psychedelics Canada

Psychedelic Trade Association Calls Out Trudeau Government, Calls on Carney and Poilievre to Improve Federal Regulations for Novel Mental Care

PsyCan Excoriates Trudeau Government for Making Assisted Suicide Harder than Psychedelic-Assisted Therapy; Calls on Carney and Poilievre to do better
October 03, 2023 07:00 ET | Source: Psychedelics Canada

The Future of Psychedelic Access in Canada: PsyCan Releases White Paper Reviewing Regulatory Options for Psychedelics

PsyCan, the trade association for the for-profit psychedelic medicine industry, releases a white paper on how Health Canada can improve access to therapies
September 07, 2023 07:30 ET | Source: Optimi Health Corp.

Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...
January 05, 2022 16:17 ET | Source: Optimi Health Corp.

Optimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)

VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...